One Biosciences and Institut Curie Secure €3.3 Million France 2030 Funding to Advance Single-Cell Diagnostics for Triple-Negative Breast Cancer One Biosciences, a techbio company spun out of Institut Curie and focused on developing clinical-grade single-cell tumor profiling technologies, and Institut…
Yarrow Bioscience Launches Underwritten Public Offering to Support Autoimmune Thyroid Disease Pipeline Yarrow Bioscience, Inc., a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, has announced the commencement of an underwritten public offering of its securities.…
Mobile Heartbeat Expands Banyan Platform with Private 5G Support for Healthcare Communications Mobile Heartbeat, a provider of clinical communication and collaboration solutions, has announced that its Banyan platform now supports private 5G networks, expanding the connectivity options available to healthcare…
BioLab Holdings Expands Placental Membrane Portfolio With New Membrane Wrap Amniotic Hydro BioLab Holdings, Inc., a Phoenix-based medical technology company focused on tissue restoration, has expanded its portfolio of placental membrane products with the addition of Membrane Wrap™ Amniotic Hydro.…
TwoStep Therapeutics Secures $62.5 Million Series A and FDA Clearance for TS-104 Phase 1 Trial TwoStep Therapeutics, a biotechnology company developing multi-specific targeted therapies for solid tumors, has announced two significant milestones that mark the company’s transition into clinical development.…
Foot Levelers Announces First-Ever Founder’s Edition PracticeXcelerator Workshop for Chiropractors Foot Levelers, a global leader in custom stabilizing orthotics, has announced its first-ever Founder’s Edition event, an expanded educational and professional development program designed specifically for chiropractors. The two-day event…
IVI RMA North America Welcomes Reproductive Endocrinologist Dr. Blake Vessa to RMA New Jersey IVI RMA North America, a leader in fertility care and assisted reproductive medicine, has announced the appointment of Dr. Blake Vessa, a reproductive endocrinologist and infertility…
Encoded Therapeutics Reports Durable Seizure Reduction and Neurodevelopmental Gains With ETX101 in Dravet Syndrome Encoded Therapeutics, Inc., a clinical-stage biotechnology company focused on developing precision genetic medicines for severe neurological disorders, has announced new Phase 1/2 clinical data for ETX101,…
GenSight Biologics Provides Summer 2026 Business and Clinical Development Updates GenSight Biologics, a biopharmaceutical company specializing in the development and commercialization of innovative gene therapies for retinal neurodegenerative diseases and disorders of the central nervous system (CNS), has announced a…
Segal Trials Employees Join CISCRP Medical Heroes Appreci-A-Thon to Honor Clinical Research Participants and Professionals More than 90 employees from Segal Trials are participating in the 8th Annual Medical Heroes Appreci-A-Thon organized by the Center for Information and Study on…
Gabrail Cancer and Research Center Receives FDA Clearance to Advance STAR-LLD and Elranatamab Study in Multiple Myeloma The Gabrail Cancer and Research Center, a PhaseWell Research site, has announced an important regulatory milestone for an investigator-initiated clinical trial evaluating STAR-LLD…
Cencora Launches Cell and Gene Therapy Enablement Service to Help Health Systems Expand Advanced Therapy Programs Cencora has launched a new service designed to help health systems evaluate, establish, and scale cell and gene therapy (CGT) programs as the number…